Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
286 questions in 57 reviews · Developmental, Psychosocial and Learning Problems
current versionsNo studies 286 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Dynamic splinting vs static splinting Need for operative intervention · babies under six months of age with stable and unstable hips Splinting for the non‐operative management of developmental dysplasia of the hip (DDH) in children under six… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Social communication at baseline and · children diagnosed with autism spectrum disorder Overall prognosis of preschool autism spectrum disorder diagnoses (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Restricted and repetitive behaviours and interests at baseline and · children diagnosed with autism spectrum disorder Overall prognosis of preschool autism spectrum disorder diagnoses (2022) · Cochrane | no estimate extracted | NR | No studies |
Physical activity interventions vs usual care Participant or parent satisfaction · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Physical activity interventions vs usual care Cost‐effectiveness · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Physical activity interventions vs usual care Delirium incidence or delirium‐free days at hospital discharge · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Physical activity interventions vs usual care Length of mechanical ventilation · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Physical activity interventions vs usual care Length of hospital stay · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Behavioral interventions vs usual care Cost‐effectiveness · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Behavioral interventions vs usual care Delirium incidence or delirium‐free days at hospital discharge · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Behavioral interventions vs usual care Length of mechanical ventilation · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Behavioral interventions vs usual care Length of hospital stay · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another… Non‐pharmacological interventions for sleep promotion in hospitalized children (2022) · Cochrane | no estimate extracted | NR | No studies |
Antidepressants vs placebo Non‐serious adverse events Timing of outcome assessment: end of treatment · people with borderline personality disorder Pharmacological interventions for people with borderline personality disorder (2022) · Cochrane | no estimate extracted | NR | No studies |
Fortification of salt with iron and iodine vs fortification of salt with iodine Blood pressure (systolic and diastolic) (mmHg) · participants were of any age or sex and from any country, regardless of baseline iron and iodine status Fortification of salt with iron and iodine versus fortification of salt with iodine alone for improving iron… (2022) · Cochrane | no estimate extracted | NR | No studies |
Training to respond to intimate partner violence vs no intervention, wait‐list or placebo on healthcare providers' attitudes towards, knowledge of and readiness to manage IPV, referrals Adverse outcomes · physicians/doctors, medical staff, medical students, residents, nurses and nursing students, dentists and dental… Training healthcare providers to respond to intimate partner violence against women (2021) · Cochrane | no estimate extracted | NR | No studies |
Immediate‐release methylphenidate vs lithium Clinical impression: severity ‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old) Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (2021) · Cochrane | no estimate extracted | NR | No studies |
Immediate‐release methylphenidate vs lithium Clinical impression: improvement‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old) Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (2021) · Cochrane | no estimate extracted | NR | No studies |
Immediate‐release methylphenidate vs lithium Harms: adverse events (poorly assessed and reported) · adults with ADHD (available evidence for participants aged between 25 to 53 years old) Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (2021) · Cochrane | no estimate extracted | NR | No studies |
Immediate‐release methylphenidate vs placebo Harms: adverse events (poorly assessed and reported) · adults with ADHD (available evidence for participants aged between 25 to 53 years old) Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (2021) · Cochrane | no estimate extracted | NR | No studies |
Immediate‐release methylphenidate vs lithium Efficacy (changes in symptoms of ADHD): participant‐rated ‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old) Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (2021) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy vs anxiety management Outcomes · obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD) Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy vs anxiety management Behavioural difficulties, end of treatment · obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD) Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with… (2021) · Cochrane | no estimate extracted | NR | No studies |
Education interventions vs no intervention Cognitive and neurobehavioural outcomes · children (aged 0–2 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Environmental interventions vs no intervention Adverse events · children (aged 0–6 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Combination interventions vs standard education Cognitive and neurobehavioural outcomes · children (aged 0–4 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Combination interventions vs standard education Adverse events · children (aged 0–4 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Education interventions vs no intervention Adverse events · children (aged 0–2 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Environmental interventions vs no intervention Household dust: floor dust lead levels · children (aged 0–6 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Environmental interventions vs no intervention Cognitive and neurobehavioural outcomes · children (aged 0–6 years) Household interventions for secondary prevention of domestic lead exposure in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Desipramine (antidepressant) vs placebo Adverse events · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Nortriptyline (antidepressant) vs placebo Aggression · men with alcohol dependency Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Nortriptyline (antidepressant) vs placebo Reconviction · men with alcohol dependency Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Nortriptyline (antidepressant) vs placebo Social functioning · men with alcohol dependency Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Bromocriptine (dopamine agonist) vs placebo Aggression · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Bromocriptine (dopamine agonist) vs placebo Reconviction · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Bromocriptine (dopamine agonist) vs placebo Social functioning · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Phenytoin (antiepileptic) vs placebo Reconviction · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Amantadine (dopamine agonist) vs placebo Aggression · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Amantadine (dopamine agonist) vs placebo Reconviction · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Amantadine (dopamine agonist) vs placebo Global state/functioning · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Amantadine (dopamine agonist) vs placebo Social functioning · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Amantadine (dopamine agonist) vs placebo Adverse events · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Phenytoin (antiepileptic) vs placebo Global state/functioning · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Phenytoin (antiepileptic) vs placebo Social functioning · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Desipramine (antidepressant) vs placebo Aggression · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Desipramine (antidepressant) vs placebo Reconviction · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Desipramine (antidepressant) vs placebo Global state/functioning · adults with antisocial personality disorder Pharmacological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Contingency management + standard maintenance vs standard maintenance alone Aggression · adults with antisocial personality disorder Psychological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Contingency management + standard maintenance vs standard maintenance alone Reconviction · adults with antisocial personality disorder Psychological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |
Contingency management + standard maintenance vs standard maintenance alone Global state/functioning · adults with antisocial personality disorder Psychological interventions for antisocial personality disorder (2020) · Cochrane | no estimate extracted | NR | No studies |